Iovance Biotherapeutics Options Trading: A Deep Dive into Market Sentiment

Recent activity in the options market has highlighted a notable bullish sentiment surrounding Iovance Biotherapeutics (NASDAQ: IOVA). An analysis of options trades for this company uncovered 11 unusual trades that signal varying trader sentiments.

Among the trades analyzed, we observed that 45% displayed bullish tendencies, while another 45% reflected bearish views. Specifically, there were 6 put options traded, amounting to a total value of $234,150, contrasted with 5 call options valued at $414,807.

Projected Price Targets

Our assessment of the volume and open interest associated with these options indicates that large investors are focusing on a potential price range for Iovance Biotherapeutics of between $7.50 and $15.00 over the last quarter.

Volume & Open Interest Trends

Examining volume and open interest provides meaningful insights for conducting thorough research on a stock.

This data can assist traders in tracking how actively Iovance Biotherapeutics's options are moving for specific strike prices.

Below, we present an overview of the changes in volume and open interest for both calls and puts related to Iovance Biotherapeutics, particularly during the last 30 days for strike prices ranging from $7.50 to $15.00.

Iovance Biotherapeutics Option Activity Analysis: Last 30 Days

Biggest Options Spotted:

Symbol	PUT/CALL	Trade Type	Sentiment	Exp. Date	Ask	Bid	Price	Strike Price	Total Trade Price	Open Interest	Volume
IOVA	CALL	SWEEP	BULLISH	03/21/25	$3.3	$3.1	$3.3	$10.00	$141.9K	2.4K	433
IOVA	CALL	SWEEP	BEARISH	12/20/24	$3.2	$3.0	$3.0	$9.00	$135.0K	6.1K	200
IOVA	CALL	SWEEP	BULLISH	03/21/25	$1.5	$1.2	$1.49	$15.00	$64.8K	891	440
IOVA	PUT	TRADE	NEUTRAL	01/16/26	$4.0	$3.8	$3.9	$12.00	$46.8K	109	362
IOVA	PUT	SWEEP	BULLISH	01/16/26	$4.0	$3.8	$3.8	$12.00	$45.6K	109	242

About Iovance Biotherapeutics

Iovance Biotherapeutics Inc. is a clinical-stage biopharmaceutical firm dedicated to revolutionizing cancer treatment by leveraging the human immune system's capacity to identify and eliminate various cancer cells. The company is preparing for the potential approval and commercialization of its first personalized autologous T-cell therapy designed for solid tumor cancers. Its mission is to lead in the innovation, development, and delivery of tumor-infiltrating lymphocyte (TIL) therapies for patients battling solid tumors.

In our evaluation of Iovance Biotherapeutics's options activities, we also take a moment to consider the company's current market position.

Iovance Biotherapeutics's Current Market Status

• Currently, IOVA has a trading volume of 1,428,846 and is down by -1.97%, priced at $11.21.
• Relative Strength Index (RSI) indicators suggest that the stock may be nearing overbought conditions.
• Upcoming earnings reports are expected within the next 2 days.

What The Experts Say On Iovance Biotherapeutics

In the past month, one analyst has provided ratings for Iovance Biotherapeutics with an average target price set at $17.00.

Can a $1000 investment turn into $1270 in just 20 days?

A seasoned options trader with 20 years of experience shares a unique chart technique to identify optimal buy and sell moments. By mirroring his trades, which have achieved an average profit of 27% every 20 days, traders can potentially boost their returns. Click here for access. * Reflecting recent concerns, an analyst from UBS has downgraded its rating to Buy, updating the price target to $17.

Options trading involves significant risks, but savvy traders can navigate these by continuously educating themselves, adjusting their strategies, monitoring multiple indicators, and staying alert to market changes. For real-time alerts related to Iovance Biotherapeutics options trading, it's essential to stay informed.

This article has provided a comprehensive view of the options trading landscape surrounding Iovance Biotherapeutics, filling you in on recent market sentiment and trader activities.

Iovance, Biotherapeutics, Options